U.S. CBD Hemp Product Revenues Predicted to Surge Over the Next Few Years

There is a lot of anticipation and optimism surrounding the medical and recreational marijuana markets revenues but the hemp/CBD market should not be ignored. A recent report from a respected industry source, BDS Analytics says that the collective market for CBD sales is expected to exceed $20 billion in the United States by 2024. This pretty much supports the reports from another industry respected source, The Brightfield Group, which has previously projected that the: “Hemp CBD Market to Reach $22 Billion By 2022: Outpacing the Rest of the Cannabis Market Combined”. It is important to understand that CBD is derived from both marijuana and hemp. One industry publication describes the difference as follows: “It is the distinction between CBD derived from marijuana and CBD from hemp oil that sets them apart. Marijuana is harvested for its buds, which contains psychoactive properties known to produce stoned effects. When it comes to hemp, the stalks and seed are the targets of this crop. These plants do not contain enough THC to get anyone high. In fact, for cannabis to be considered hemp, it must have no more than 0.3 percent THC. Just think of hemp oil-based CBD as a vitamin (high in Potassium and Magnesium) and the bud-based products to be pharmaceutical grade.” Active Companies in the market this week include: MYM Nutraceuticals Inc., (CSE: MYM) (OTCQB: MYMMF), Aurora Cannabis Inc. (NYSE: ACB) (TSX: ACB), Curaleaf Holdings, Inc. (CSE: CURL) (OTCQX: CURLF), Village Farms International, Inc. (NASDAQ: VFF) (TSX: VFF), CV Sciences, Inc. (OTCQB: CVSI).

CV Sciences, Inc. to Announce Second Quarter 2019 Results on August 6, 2019

CV Sciences, Inc.(OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”) announced that it will release financial results for its second quarter 2019 ended June 30, 2019, after the stock market closes on Tuesday, August 6, 2019. The Company will hold a conference call with the investment community at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) that same day.
Stock Symbols

CBD Retail Boom Expands With The Kroger Co.

CBD just got another major shot in the arm. Just days ago, Kroger announced it would sell CBD products in nearly 1,000 stores. While it won’t sell CBD-infused groceries yet, it will carry CBD topical products, including creams, balms and oils in 945 stores across 17 states. The company joins a growing list of other retailers that are just now jumping on the bandwagon. Simon Property Group partnered with Green Growth Brands. CVS will now carry CBD products across the U.S. The Vitamin Shoppe announced it will sell CBD products. Abercrombie & Fitch just partnered with Green Growth Brands to sell CBD body care products. In addition, analysts at Jefferies estimate the CBD beauty market will reach $25 billion over the next 10 years. That’s opening a wide range of opportunity for companies including The Yield Growth Corp. (CSE:BOSS) (OTCQB:BOSQF), CV Sciences Inc. (OTCQB:CVSI), Aurora Cannabis Inc. (NYSE:ACB) (TSX:ACB), CannTrust Holdings Inc. (NYSE:CTST)(TSX:TRST), and Canopy Rivers Inc. (TSX-V:RIV)(OTCPK:CNPOF).

Retailers are Racing to Meet Sizable Worldwide Demand for CBD

According to the Brightfield Group, worldwide CBD sales are expected to soar from $591 million in 2018 to as high as $22 billion by 2022 – a compound growth rate of 147%. All as consumers and retailers clamor for CBD products. Simon Property Group is partnering with Green Growth Brands. CVS will now carry CBD products across the U.S. The Vitamin Shoppe just announced it will sell CBD products. In addition, Abercrombie & Fitch just partnered with Green Growth Brands to sell CBD body care products. Some of the stocks benefiting from the cannabis market boom include Lifestyle Delivery Systems Inc. (CSE:LDS)(OTCQX:LDSYF), CV Sciences Inc. (OTCQB:CVSI), Cresco Labs Inc. (CSE:CL)(OTCQX:CRLBF), Curaleaf Holdings Inc. (CSE:CURA)(OTCQX:CURLF), and Harvest Health & Recreation Inc. (CSE:HARV)(OTCQX:HRVSF).

CV Sciences Comments on FDA CBD Hearing

Top hemp CBD Company urges FDA to swiftly develop regulations to separate an agricultural commodity from a controlled substance and ensure consumer safety
Stock Symbols

Upcoming CBD Shortage is an Opportunity for Cost-efficient Producers to Expand

Few developments have been as game-changing for the cannabis industry as the U.S. Farm Bill. While demand for cannabis will remain strong over the upcoming years, experts are anticipating that the hemp industry will become a new big player in the marketplace. Ever since hemp agriculture was legalized thanks to the U.S. Farm Bill signed December last year, cannabis companies around the world have jumped on the opportunity to get in on ground zero of this sector. Well known Canadian listed companies such as Charlotte’s Web Holdings Inc. (CSE:CWEB), CV Sciences Inc. , Liberty Health Sciences (CSE:LHS), Namaste Technologies , and StillCanna Inc. (CSE:STIL) have all been making major moves in the growing hemp market.